Dennise Ramirez, PA-C

Dennise Ramirez practices at Optum Radiology at Crystal Run - Middletown in Middletown, New York.

Dennise Ramirez's NPI, 1134695141, was assigned on October 17, 2018. Dennise Ramirez holds New York license 031661.

Dennise Ramirez's primary practice is Optum Radiology at Crystal Run - Middletown, at 95 Crystal Run Rd, Middletown, NY 10941. The practice phone is (845) 703-6366.

Dennise Ramirez's primary practice is Optum Radiology at Crystal Run - Middletown in Middletown, New York. Dennise Ramirez is also affiliated with Garnet Health Medical Center. The medical group on file is Crystal Run Healthcare. Dmand AI also links Dennise Ramirez to 1 more group practice or clinic and 1 medical group, each named with a free account. Dennise Ramirez's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dennise Ramirez practices, 3 sites in all. Vendor and product names are available with a free account.

Medical is Dennise Ramirez's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Dennise Ramirez is licensed in New York.

Dmand AI lists acute skin infection, bladder disease, enlarged prostate and UTI among the conditions Dennise Ramirez treats.

CMS data shows 122 Medicare services from Dennise Ramirez across 5 procedure codes in 2024, for 151 Medicare patients. Medicare paid $8,329 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 151 Medicare patients who saw Dennise Ramirez in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dennise Ramirez's median patient age at 57, with 64% women.

In 2024, Dennise Ramirez wrote 328 Medicare Part D claims for 176 patients. 80% of them were for generic drugs. CMS names the drug for 257 of them, across 11 drugs with 11 or more claims each, at $53,538 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dennise Ramirez for performance year 2024, reported as part of a group. Dennise Ramirez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dennise Ramirez as offering telehealth.

CMS Open Payments shows 2 general payments to Dennise Ramirez from 2 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $125.